SK Capital Partners

SK Capital Partners is a global private investment firm with approximately $9 billion in assets under management. The firm specializes in investing in and transforming companies within the specialty materials, ingredients, and life sciences sectors. Its portfolio includes businesses involved in pharmaceuticals manufacturing (e.g., contract manufacturing), radiopharmaceuticals for diagnostics/therapeutics, plant-derived APIs for pharma use, and medical technology. The firm's investments have led to significant growth and operational improvements across its holdings. It does not develop drugs or technologies itself but enables such activities through its portfolio companies.